The molecular mechanisms of offspring effects from obese pregnancy

Obesity Facts

Volumn 6, Issue 2, 2013, Pages 134-145

  Dowling, Daniel ^a   McAuliffe, Fionnuala M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Epigenetics; Maternal obesity; Reactive oxygen species

Indexed keywords

ARACHIDONIC ACID; NITRIC OXIDE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE;

EPIGENETICS; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOTOXICITY; MATERNAL OBESITY; NONHUMAN; PHENOTYPE; PLACENTA FUNCTION; PREGNANCY; PRIORITY JOURNAL; PROGENY; REVIEW;

EID: 84875860233     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000350706     Document Type: Review

References (89)

1. Higgins M, Mc Auliffe FM: A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev 2010; 6: 116-125.
2. Junien C, Nathanielsz P: Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes. Obes Rev 2007; 8: 487-502.
3. Barker DJP: The origins of the developmental origins theory. J Intern Med 2007; 261: 412-417.
4. Higgins MF, Russell NM, Mulcahy CH, Coffey M, Foley ME, McAuliffe FM: Fetal anterior abdominal wall thickness in diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 2008; 140: 43-47.
5. Herring S, Oken E: Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle? Curr Diabetes Rep 2011; 11: 20-27.
6. Khandaker GM, Dibben CRM, Jones PB: Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring? Obesi Rev 201213: 518-527.
7. Patel SP, Rodriguez A, Little MP, Elliott P, Pekkanen J, Hartikainen A-L, Pouta A, Laitinen J, Harju T, Canoy D, Järvelin MR: Associations between pre-pregnancy obesity and asthma symptoms in adolescents. J Epidemiol Community Health 2012; 66: 809-814.
8. Barker DJP. Obesity and early life. Obes Rev 2007; 8: 45-49.
9. Smith J, Cianflone K, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S, Kral JG, Marceau P: Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrin Metab 2009; 94: 4275-4283.
10. Armitage JA, Lakasing L, Taylor PD, Balachandran AA, Jensen RI, Dekou V, Ashton N, Nyengaard JR, Poston L: Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol 2005; 565: 171-184.
11. Fernandes C, Grayton H, Poston L, Samuelsson AM, Taylor PD, Collier DA, Rodriguez A: Prenatal exposure to maternal obesity leads to hyperactivity in offspring. Mol Psychiatry 2012; 17: 1159-1160.
12. Oben JA, Patel T, Mouralidarane A, Samuelsson AM, Matthews P, Pombo J, Morgan M, McKee C, Soeda J, Novelli M, Poston L, Taylor P: Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun2010; 394: 24-28.
13. Samuelsson A-M, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EHJM, Piersma AH, Ozanne SE, Twinn DF, Remacle C, Rowlerson A, Poston L, Taylor PD: Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance. Hypertension 2008; 51: 383-392.
14. Samuelsson A-M, Morris A, Igosheva N, Kirk SL, Pombo JMC, Coen CW, Poston L, Taylor PD: Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. Hypertension 2010; 55: 76-82.
15. Henry SL, Barzel B, Wood-Bradley RJ, Burke SL, Head GA, Armitage JA: The developmental origins of obesityrelated hypertension. Clin Exp Pharmacol Physiol 2012; 39: 799-806.
16. Simmons D: Diabetes and obesity in pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25: 25-36.
17. Ovesen P, Rasmussen S, Kesmodel U: Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol 2011; 118: 305-312.
18. Lucas A: Programming by early nutrition in man. Ciba Foundation Symposium 1991; 156: 38-50.
19. Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among us adults, 1999-2008. JAMA 2010; 303: 235-241.
20. Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-1437.
21. Hyppönen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK, Childhood Diabetes in Finland Study Group: Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 2000; 23: 1755-1760.
22. Jawerbaum A, White V: Animal models in diabetes and pregnancy. Endocr Rev 2010; 31: 680-701.
23. McGowan CA, McAuliffe FM: The influence of maternal glycaemia and dietary glycaemic index on pregnancy outcome in healthy mothers. Br J Nutr 2010; 104: 153-159.
24. Ringrose L, Paro R: Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins. Annu Rev Genet 2004; 38: 413-443.
25. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
26. Walsh JM, Mahony R, Byrne J, Foley M, McAuliffe FM: The association of maternal and fetal glucose homeostasis with fetal adiposity and birthweight. Eur J Obstet Gynecol Reprod Biol 2011; 159: 338-341.
27. Corrigan N, Brazil DP, McAuliffe F: Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol 2009; 85: 523-530.
28. Jawerbaum A, Gonzalez E: The Role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des 2005; 11: 1327-1342.
29. Williams IL, Wheatcroft SB, Shah AM, Kearney MT: Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord 2002; 26(6):754-764.
30. González E, Jawerbaum A, Novaro V, Sinner D, Gimeno M: Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat. Prostaglandins Leukot Essent Fatty Acids 1998; 59: 299-304.
31. Stefan J, Schmieder RE: Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens 2000; 18:363-374.
32. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME: Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73:205-209.
33. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : A specific vascular action of insulin. Circulation 2000; 101:676-681.
34. Thaler CD, Epel D: Nitric oxide in oocyte maturation, ovulation, fertilization, cleavage and implantation: A little dab'll do ya. Curr Pharm Des 2003; 9: 399-409.
35. Colton SA, Humpherson PG, Leese HJ, Downs SM: Physiological changes in oocyte-cumulus cell complexes from diabetic mice that potentially influence meiotic regulation. Biol Reprod 2003; 69: 761-770.
36. Diamond MP, Moley KH, Pellicer A, Vaughn WK, DeCherney AH: Effects of streptozotocin-and alloxan-induced diabetes mellitus on mouse follicular and early embryo development. J Reprod Fertil 1989; 86: 1-10.
37. Moley K, Chi M-Y, Knudson C, Korsmeyer S, Mueckler M: Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4: 1421-1424.
38. Moley KH, Chi MM, Mueckler MM: Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. Am JPhysiol 11998; 275:E38-E47.
39. Moley KH: Diabetes and preimplantation events of embryogenesis. Semin Reprod Med 1999; 17: 137-151.
40. Wang Q, Moley KH: Maternal diabetes and oocyte quality. Mitochondrion 2010; 10: 403-410.
41. De Hertogh R, Vanderheyden I, Pampfer S, Robin D, Delcourt J: Maternal insulin treatment improves preimplantation embryo development in diabetic rats. Diabetologia 1992; 35: 406-408.
42. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271:C1424-C1437.
43. Cuzzocrea S, Caputi A, Zingarelli B: Peroxynitrite-mediated DNA strand breakage activates poly (ADP-ribose) synthetase and causes cellular energy depletion in carrageenan-induced pleurisy. Immunology 1998; 93: 96-101.
44. Tsutsui H, Kinugawa S, Matsushima S: Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011; 301:H2181-H2190.
45. Nakamura T, Goda K, Okamoto T, Kishi T, Nakamura T, Goshima K: Contractile and morphological impairment of cultured fetal mouse myocytes induced by oxygen radicals and oxidants. Correlation with intracellular Ca2+ concentration. Circ Res 1993; 73: 758-770.
46. Zima AV, Blatter LA: Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006; 71: 310-321.
47. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279-286.
48. Eriksson UJ, Borg LA: Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 1993; 42: 411-419.
49. Takimoto E, Kass DA: Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007; 49: 241-248.
50. Cheng T-H, Cheng P-Y, Shih N-L, Chen I-B, Wang DL, Chen J-J: Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 2003; 42: 1845-1854.
51. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong T-T, Shaw RM, Srivastava D: Cardiac fibroblasts regulate myocardial proliferation through 1 integrin signaling. Dev Cell 2009; 16: 233-244.
52. Baudino TA, Carver W, Giles W, Borg TK: Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 2006; 291:H1015-H1026.
53. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin ii-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11-34.
54. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S: ERK and p38 MAPK, but not NF-B, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 2001; 89: 661-669.
55. Mills JL, Troendle J, Conley MR, Carter T, Druschel CM: Maternal obesity and congenital heart defects: A population-based study. Am J Clin Nutr 2010; 91: 1543-1549.
56. Wang J, Ma H, Tong C, Zhang H, Lawlis GB, Li Y, Zang M, Ren J, Nijland MJ, Ford SP, Nathanielsz PW, Li J: Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB J 2010; 24: 2066-2076.
57. Calvert JW, Lefer DJ, Gundewar S, Poston L, Coetzee WA: Developmental programming resulting from maternal obesity in mice: effects on myocardial ischaemia-reperfusion injury. Exp Physiol 2009; 94: 805-814.
58. Ehrenberg HM, Huston-Presley L, Catalano PM: The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003; 189: 944-948.
59. Soltani H, Fraser RB: A longitudinal study of maternal anthropometric changes in normal weight, overweight and obese women during pregnancy and postpartum. Br J Nutr 2000; 84: 95-101.
60. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ: Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci 2010; 119: 123-129.
61. Jensen MD: Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93(11 suppl 1):s57-s63.
62. Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U: Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab 2009; 297:E999-E1003.
63. Trauner M, Arrese M, Wagner M: Fatty liver and lipotoxicity. Biochim Biophys Acta 2010; 1801: 299-310.
64. Imrie H, Abbas A, Kearney M: Insulin resistance, lipotoxicity and endothelial dysfunction. Biochim Biophys Acta 2010; 1801: 320-326.
65. Pavan L, Hermouet A, Tsatsaris V, Thérond P, Sawamura T, Evain-Brion D, Fournier T: Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 2004; 145: 4583-4591.
66. Zhu MJ, Ma Y, Long NM, Du M, Ford SP: Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. Am J Physiol Regul Integr Comp Physiol 2010; 299:R1224-R1231.
67. Larqué E, Demmelmair H, Berger B, Hasbargen U, Koletzko B: In vivo investigation of the placental transfer of 13C-labeled fatty acids in humans. J Lipid R 2003; 44: 49-55.
68. Jensen J, Rustad PI, Kolnes AJ, Lai Y-C: The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise. Front Physiol. 2011; 2: 112.
69. Hagemann LL, Zielinsky P: Prenatal study of hypertrophic cardiomyopathy and its association with insulin levels in fetuses of diabetic mothers (in Portugese). Arq Bras Cardiol 1996; 66:193-198.
70. Zielinsky P, da Costa MH, Oliveira LT, Bonow FP, da Silva NI, Hagemann LL: Natural history of myocardial hypertrophy and its association with hyperinsulinism in infants of diabetic mothers (in Portugese). Arq Bras Cardiol 1997; 69: 389-394.
71. Krüger M, Babicz K, von Frieling-Salewsky M, Linke WA: Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J Mol Cell Cardiol 2010; 48: 910-916.
72. Krüger M, Kötter S, Grützner A, Lang P, Andresen C, Redfield MM, Butt E, dos Remedios CG, Linke WA: Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 2009; 104: 87-94.
73. Krüger M, Linke W: Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil 2006; 27: 435-44.
74. Grützner A, Garcia-Manyes S, Kötter S, Badilla CL, Fernandez JM, Linke WA: Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J 2009; 97: 825-834.
75. Falcão-Pires I, Hamdani N, Borbély A, Gavina C, Schalkwijk CG, van der Velden J, van Heerebeek L, Stienen GJ, Niessen HW, Leite-Moreira AF, Paulus W: Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness / clinical perspective. Circulation 2011; 124: 1151-1159.
76. Steculorum SM, Bouret SG: Maternal diabetes compromises the organization of hypothalamic feeding circuits and impairs leptin sensitivity in offspring. Endocrinology 2011; 152: 4171-4179.
77. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
78. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1-808.
79. Roche HM: Fatty acids and the metabolic syndrome. Proc Nutr Soc 2005; 64: 23-29.
80. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS: Tumor necrosis factor-stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002; 51: 2929-2935.
81. Sarkanen J-R, Kaila V, Mannerström B, Räty S, Kuokkanen H, Miettinen S, Ylikomi T: Human adipose tissue extract induces angiogenesis and adipogenesis in vitro. Tissue Eng Part A 2012; 18: 17-25.
82. Smith NA, McAuliffe FM, Quinn K, Lonergan P, Evans ACO: The negative effects of a short period of maternal undernutrition at conception on the glucose-insulin system of offspring in sheep. Anim Reprod Sci 2010; 121: 94-100.
83. Bouret SG, Simerly RB: Developmental programming of hypothalamic feeding circuits. Clin Gene 2006; 70: 295-301.
84. Djiane J, Attig L: Role of leptin during perinatal metabolic programming and obesity. J Physiol Pharmacol 2008; 59: 55-63.
85. Kirk SL, Samuelsson AM, Argenton M, Dhonye H, Kalamatianos T, Poston L, Taylor PD, Coen CW: Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS ONE 2009; 4:e5870.
86. Smith NA, McAuliffe FM, Quinn K, Lonergan P, Evans ACO: Transient high glycaemic intake in the last trimester of pregnancy increases offspring birthweight and postnatal growth rate in sheep: A randomised control trial. BJOG 2009; 116: 975-983.
87. Plagemann A, Harder T, Brunn M, Harder A, Roepke K, Wittrock-Staar M, Ziska T, Schellong K, Rodekamp E, Melchior K, Dudenhausen JW: Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: An epigenetic model of obesity and the metabolic syndrome. J Physiol 2009; 587: 4963-4976.
88. Dunn GA, Bale TL: Maternal high-fat diet promotes body length increases and insulin insensitivity in secondgeneration mice. Endocrinology 2009; 150: 4999-5009.
89. Poston L: Developmental programming and diabetes-the human experience and insight from animal models. Best Pract Res Clin Endocrinol Metab 2010; 24: 541-552.